bia 28-6156
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 28, 2021 (NCT05220072)
Timeline
Indications
Studied for
Mechanism of action
- Beta-glucocerebrosidaseACTIVATOR
GBA activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05819359 | Phase 2 | Mar 31, 2023 | Bial |
| NCT05220072 | Phase 1 | Aug 28, 2021 | Bial, Quotient |
Showing 2 of 2 trials
Page 1 / 1